These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16683456)

  • 21. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
    Liu HW; Chen CH; Tsai CL; Hsiue GH
    Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of leptin on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in nude mice.
    Xu JC; Wu GH; Liu HL; Liu JT; Yan XJ; Chen JT
    Saudi Med J; 2010 Jun; 31(6):615-21. PubMed ID: 20563357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
    Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
    J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
    Kodama T; Goto T; Miyazaki T; Takahashi T
    Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone healing process in critical-sized defects by rhBMP-2 using poloxamer gel and collagen sponge as carriers.
    Issa JP; do Nascimento C; Iyomasa MM; Siéssere S; Regalo SC; Defino HL; Sebald W
    Micron; 2008; 39(1):17-24. PubMed ID: 17923409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human bone morphogenetic protein-2 on midsagittal sutural bone formation during expansion.
    Liu SS; Opperman LA; Buschang PH
    Am J Orthod Dentofacial Orthop; 2009 Dec; 136(6):768.e1-8; discussion 768-9. PubMed ID: 19962596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Repair of articular cartilage defect with poly-lactide-co-glycolide loaded with recombinant human bone morphogenetic protein in rabbits].
    Cui Y; Wu J; Hu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1233-7. PubMed ID: 18069483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical study of recombinant human bone morphogenetic protein-2: application of hyperbaric oxygenation during bone formation under unfavourable condition.
    Okubo Y; Bessho K; Fujimura K; Kusumoto K; Suzuki T; Segami N; Ogawa Y; Iizuka T
    Int J Oral Maxillofac Surg; 2003 Jun; 32(3):313-7. PubMed ID: 12767880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
    Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of the expression profile during the entochondrostosis of vascular endothelial growth factor in bone morphogenetic protein 2 induced osteogenesis].
    Tang X; Fu DH; Yang SH; Chen YC; Li Q; Yu CN; Xu WH; Li J; Ye SN
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):614-7. PubMed ID: 18844060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia.
    Johansson O; Liang Y; Emtestam L
    Arch Dermatol Res; 2002 Feb; 293(12):614-9. PubMed ID: 11875644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
    Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
    J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages.
    Ishikawa H; Kitoh H; Sugiura F; Ishiguro N
    Acta Orthop; 2007 Apr; 78(2):285-92. PubMed ID: 17464620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of NGF and its receptors in ovaries from human fetuses and adults.
    Abir R; Fisch B; Jin S; Barnnet M; Ben-Haroush A; Felz C; Kessler-Icekson G; Feldberg D; Nitke S; Ao A
    Mol Hum Reprod; 2005 Apr; 11(4):229-36. PubMed ID: 15829579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model.
    Hall J; Sorensen RG; Wozney JM; Wikesjö UM
    J Clin Periodontol; 2007 May; 34(5):444-51. PubMed ID: 17448048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds.
    Hou LT; Liu CM; Liu BY; Chang PC; Chen MH; Ho MH; Jehng SM; Liu HC
    J Periodontol; 2007 Feb; 78(2):335-43. PubMed ID: 17274724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of nerve growth factor and its high-affinity receptor, tyrosine kinase A proteins, in the human scalp skin.
    Adly MA; Assaf HA; Nada EA; Soliman M; Hussein M
    J Cutan Pathol; 2006 Aug; 33(8):559-68. PubMed ID: 16919030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.